secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASPEN AEROGELS INC (ASPN)
CIK:        0001145986
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001171843-24-002426
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspen Aerogels Q1 revenue $94.5M, Adjusted EBITDA $12.9M, raises FY2024 EBITDA outlook 83%
--------------------------------------------------------------------------------

- Revenue $94.5M, up 107% YoY from $45.6M; net loss narrowed to $1.8M from $16.8M.
- Adjusted EBITDA of $12.9M, compared to $(13.9)M in Q1 2023; a $26.8M improvement.
- Raising 2024 baseline Adjusted EBITDA outlook by 83%; expects positive net income for full year 2024.
- Diluted EPS loss of $0.02, compared to loss of $0.24 in Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145986/000117184324002426/0001171843-24-002426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145986/000117184324002426/f8k_050124.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer